Neuropace, Inc. NPCE Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s operating income?
- Neuropace, Inc. (NPCE) reported operating income of -$5.57M in Q1 2026.
- How has Neuropace, Inc.'s operating income changed year-over-year?
- Neuropace, Inc.'s operating income decreased by 8.2% year-over-year, from -$5.15M to -$5.57M.
- What is the long-term trend for Neuropace, Inc.'s operating income?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s operating income has grown at a -8.9% compound annual growth rate (CAGR), from -$23.74M to -$16.34M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.